|
[1] GAO W,WANG K,MA N,et al. Living donor liver transplantations for pediatric patients withbiliary atresia in a single center:306[J]. Chin J Organ Transplant,2019,41(1):13-17.(in Chinese)高伟，王凯，马楠，等．亲属活体肝移植治疗儿童胆道闭锁306例临床分析[J]．中华器官移植杂志，2019,41(1):13-17.
|
|
[2] NEPOM GT,ST CLAIR EW,TURKA LA. Challenges in the pursuit of immune tolerance[J]. Immunol Rev,2011,241(1):49-62.
|
|
[3] WALDMANN H. Tolerance:An overview and perspectives[J]. Nat Rev Nephrol,2010,6(10):569-576.
|
|
[4] de la GARZA RG,SAROBE P,MERINO J,et al. Trial of complete weaning from immunosuppression for liver transplant recipients:Factors predictive of tolerance[J]. Liver Transpl,2013,19(9):937-944.
|
|
[5] STARZL TE,DEMETRIS AJ,TRUCCO M,et al. Cell migration and chimerism after whole-organ transplantation:The basis of graft acceptance[J]. Hepatology,1993,17(6):1127-1152.
|
|
[6] MAZARIEGOS GV,REYES J,MARINO IR,et al. Weaning of immunosuppression in liver transplant recipients[J]. Transplantation,1997,63(2):243-249.
|
|
[7] ORLANDO G,MANZIA T,BAIOCCHI L,et al. The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients:The updated follow up at 78 months[J].Transpl Immunol,2008,20(1-2):43-47.
|
|
[8] BENSELER V,TAY SS,BOWEN DG,et al. Role of the hepatic parenchyma in liver transplant tolerance:A paradigm revisited[J]. Dig Dis,2011,29(4):391-401.
|
|
[9] CRISPE IN. Immune tolerance in liver disease[J]. Hepatology,2014,60(6):2109-2117.
|
|
[10] SCHILDBERG FA,SHARPE AH,TURLEY SJ. Hepatic immune regulation by stromal cells[J]. Curr Opin Immunol,2015,32:1-6.
|
|
[11] DEMETRIS AJ,BELLAMY CO,GANDHI CR,et al. Functional immune anatomy of the liver-as an allograft[J]. Am J Transplant,2016,16(6):1653-1680.
|
|
[12] DEMETRIS AJ,MURASE N,NAKAMURA K,et al. Immunopathology of antibodies as effectors of orthotopic liver allograft rejection[J]. Semin Liver Dis,1992,12(1):51-59.
|
|
[13] FENG S,EKONG UD,LOBRITTO SJ,et al. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants[J]. JAMA,2012,307(3):283-293.
|
|
[14] TAKATSUKI M,UEMOTO S,INOMATA Y,et al. Weaning of immunosuppression in living donor liver transplant recipients[J]. Transplantation,2001,72(3):449-454.
|
|
[15] DIJKE IE,HOEPPLI RE,ELLIS T,et al. Discarded human thymus is a novel source of stable and long-lived therapeutic regulatory T cells[J]. Am J Transplant,2016,16(1):58-71.
|
|
[16] FOOTE JB,KOK M,LEATHERMAN JM,et al. A sting agonist given with OX40 receptor and PD-L1 modulators primes immunity and reduces tumor growth in tolerized mice[J]. Cancer Immunol Res,2017,5(6):468-479.
|
|
[17] KUMAR P,ALHARSHAWI K,BHATTACHARYA P,et al. Soluble OX40L and JAG1 induce selective proliferation of functional regulatory Tcells independent of canonical TCR signaling[J].Sci Rep,2017,7:39751.
|
|
[18] BAEYENS A,SAADOUN D,BILLIARD F,et al. Effector T cells boost regulatory T cell expansion by IL-2,TNF,OX40,and plasmacytoid dendritic cells depending on the immune context[J]. J Immunol,2015,194(3):999-1010.
|
|
[19] FEHR T,SYKES M. Clinical experience with mixed chimerism to induce transplantation tolerance[J]. Transpl Int,2008,21(12):1118-1135.
|
|
[20] MATHEW JM,LEVENTHAL JR,MILLER J. Microchimerism in promoting graft acceptance in clinical transplantation[J]. Curr Opin Organ Transplant,2011,16(4):345-352.
|
|
[21] SCANDLING JD,BUSQUE S,SHIZURU JA,et al. Induced immune tolerance for kidney transplantation[J]. N Engl J Med,2011,365(14):1359-1360.
|
|
[22] MORRIS H,DEWOLF S,ROBINS H,et al. Tracking donorreactive T cells:Evidence for clonal deletion in tolerant kidney transplantpatients[J]. Sci Transl Med, 2015, 7(272):272ra10.
|
|
[23] HUTCHINSON JA,RIQUELME P,SAWITZKI B,et al. Cutting edge:Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients[J]. J Immunol,2011,187(5):2072-2078.
|
|
[24] BEZIE S,PICARDA E,OSSART J,et al. Compensatory regulatory networks between CD8 T,B,and myeloid cells in organ transplantation tolerance[J]. J Immunol,2015,195(12):5805-5815.
|
|
[25] WANG K,LIU K,ZHOU CL,et al. Expressions of Treg/Th17cells in post liver transplantation acute rejection in pediatric recipients diagnosed with biliary atresia[J]. Chin J Hepatobiliary Surg,2019,25(1):5-9.(in Chinese)王凯，刘凯，周春雷，等．Treg/Th17细胞在胆道闭锁儿童肝移植术后急性排斥反应中的变化[J]．中华肝胆外科杂志，2019,25(1):5-9.
|
|
[26] TAUBERT R,DANGER R,LONDONO MC,et al. Hepatic infiltrates in operational tolerant patients after liver transplantation show enrichment of regulatory T cells before proinflammatory genes are downregulated[J]. Am J Transplant,2016,16(4):1285-1293.
|
|
[27] HAJKOVA M,HERMANKOVA B,JAVORKOVA E,et al. Mesenchymal stem cells attenuate the adverse effects of immunosuppressive drugs on distinct T cell subopulations[J]. Stem Cell Rev,2017,13(1):104-115.
|
|
[28] WHITEHOUSE G,GRAY E,MASTORIDIS S,et al. IL-2 therapy restores the impaired function of regulatory T cells induced by calcineurin inhibitors[J]. Proc Natl Acad Sci U S A,2017,114(27):7083-7088.
|
|
[29] KIM N,CHO SG. Overcoming immunoregulatory plasticity of mesenchymal stem cells for accelerated clinical applicationsTracking donor-reactive T cells:Evidence for clonal deletion in tolerant kidney transplantpatients[J]. Int J Hematol,2016,103(2):129-137.
|
|
[30] YOUNG JS,YIN D,VANNIER AGL,et al. Equal expansion of endogenous transplant-specific regulatory T cell and recruitment into the allograft during rejection and tolerance[J]. Front Immunol,2018,9:1385.
|
|
[31] TODO S,YAMASHITA K,GOTO R,et al. A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation[J]. Hepatology,2016,64(2):632-643.
|
|
[32] BRUNSTEIN CG,MILLER JS,MCKENNA DH,et al. Umbilical cord blood-derived T regulatory cells to prevent GVHD:Kinetics,toxicity profile,and clinical effect[J]. Blood,2016,127(8):1044-1051.
|
|
[33] WANG K,JIAGN WT,GAO W,et al. Effects of different immunosuppressants on peripheral CD4+CD25+FoxP3+regulatory T cells in post liver transplant patients[J]. Chin J Gen Surg,2015,30(2):135-139.(in Chinese)王凯，蒋文涛，高伟，等．不同免疫抑制剂对肝移植术后CD4+CD25+FoxP3+调节性T细胞的影响[J]．中华普通外科杂志，2015,30(2):135-139.
|
|
[34] HULL CM,NICKOLAY LE,ESTORNINHO M,et al. Generation of human islet-specific regulatory T cells by TCR gene transfer[J]. J Autoimmun,2017,79:63-73.
|
|
[35] BOARDMAN D,MAHER J,LECHLER R,et al. Antigen-specificity using chimeric antigen receptors:the future of regulatory T-cell therapy?[J]. Biochem Soc Trans,2016,42(2):342-348.
|
|
[36] ZHANG Q,LU W,LIANG CL,et al. Chimeric Antigen Receptor(CAR)Treg:A promising approach to inducing immunological tolerance[J]. Front Immunol,2018,9:2359.
|
|
[37] BOURDEAUX C,PIRE A,JANSSEN M,et al. Prope tolerance after pediatric liver transplantation[J]. Pediatr Transplant,2013,17(1):59-64.
|
|
[38] Banff Working Group on Liver Allograft Pathology. Importance of liver biopsy findings in immunosuppression management:Biopsy monitoring and working criteria for patients with operational tolerance[J]. Liver Transpl,2012,18(10):1154-1170.
|
|
[39] BENITEZ C,LONDONO MC,MIQUEL R,et al. Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients[J]. Hepatology,2013,58(5):1824-1835
|
|
[40] DEMETRIS AJ,ISSE K. Tissue biopsy monitoring of operational Tolerance in liver allograft recipients[J]. Curr Opin Organ Transplant,2013,18(3):345-353.
|
|
[41] FENG S,DEMETRIS AJ,SPAIN KM,et al. Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R[J]. Hepatology,2017,65(2):647-660.
|
|
[42] WAKI K,SUGAWARA Y,MIZUTA K,et al. Predicting operational tolerance in pediatric living-donor liver transplantation by absence of HLA antibodies[J]. Transplantation,2013,95(1):177-183.
|
|
[43] OHE H,WAKI K,YOSHITOMI M,et al. Factors affecting operational tolerance after pediatric living-donor liver transplantation:Impact of early post-transplant events and HLA match[J]. Transpl Int,2012,25(1):97-106.
|
|
[44] YOSHITOMI M,KOSHIBA T,HAGA H,et al. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation[J]. Transplantation,2009,87(4):606-614.
|
|
[45] LEE JH,LEE SK,LEE HJ,et al. Withdrawal of immunosuppression in pediatric liver transplant recipients in Korea[J].Yonsei Med J,2009,50(6):784-788.
|
|
[46] LIN NC,WANG HK,YEH YC,et al. Minimization or withdrawal of immunosuppressants in pediatric liver transplant recipients[J]. J Pediatr Surg,2015,50(12):2128-2133.
|
|
[47] KIM JJ,MARKS SD. Long-term outcomes of children after solid organ transplantation[J]. Clinics(Sao Paulo),2014,69(Suppl 1):28-38.
|
|
[48] JHUN J,LEE SH,LEE SK,et al. Serial monitoring of immune markers being represented regulatory T Cell/T helper 17 cell ratio:Indicating tolerance for tapering immunosuppression after liver transplantation[J]. Front Immunol,2018,9:352.
|
|
[49] LAU AH,VITALONE MJ,HAAS K,et al. Mass cytometry reveals a distinct immunoprofile of operational tolerance in pediatric liver transplantation[J]. Pediatr Transplant,2016,20(8):1072-1080.
|
|
[50] KONG X,SUN R,CHEN Y,et al．γδT cells drive myeloidderived suppressor cell-mediated CD8+T cell exhaustion in hepatitis B virus-induced immunotolerance[J]. J Immunol,2014,193(4):1645-1653.
|
|
[51] ZHAO X,LI Y,OHE H,et al. Intragraft Vδ1γδT cells with a unique T-cell receptor are closely associated with pediatricsemiallogeneic liver transplant tolerance[J]. Transplantation,2013,95(1):192-202.
|
|
[52] PUIG-PEY I,BOHNE F,BENITEZ C,et al. Characterization ofγδT cell subsets in organ transplantation[J]. Transpl Int,2010,23(10):1045-1055.
|
|
[53] GOLDSCHMIDT I,KARCH A,MIKOLAJCZYK R,et al. Immune monitoring after pediatric liver transplantation-the prospective Chil SFree cohort study[J]. BMC Gastroenterol,2018,18(1):63.
|
|
[54] LI L,WOZNIAK LJ,RODDER S,et al. A common peripheral blood gene set for diagnosis of operational tolerance in pediatric and adult liver transplantation[J]. Am J Transplant,2012,12(5):1218-1228.
|
|
[55] ZHONG KB,ZHANG P,HE XS,et al. Immune parameters to serve as biomarkers and clinical significance in tolerant patients after liver transplantations[J]. Chin J Hepatobiliary Surg,2016,22(2):78-81.(in Chinese)钟克波，张鹏，何晓顺，等．肝移植术后免疫耐受患者相关指标的变化及其临床意义[J]．中华肝胆外科杂志，2016,22(2):78-81.
|
|
[56] KOSHIBA T,LI Y,TAKEMURA M,et al. Clinical,immunological,and pathological aspects of operational tolerance after pediatric living-donor liver transplantation[J]. Transpl Immunol,2007,17(2):94-97.
|
|
[57] LIU XQ,HU ZQ,PEI YF,et al. Clinical operational tolerance in liver transplantation:state-of-the-art perspective and future prospects[J]. Hepatobiliary Pancreat Dis Int,2013,12(1):12-33.
|
|
[58] DEMETRIS AJ,LUNZ JG,RANDHAWA P,et al. Monitoring of human liver and kidney allograft tolerance:A tissue/histopathology perspective[J]. Transpl Int,2009,22(1):120-141.
|
|
[59] MIYAGAWA-HAYASHINO A,YOSHIZAWA A,UCHIDA Y,et al. Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts[J].Liver Transpl,2012,18(11):1333-1342.
|
|
[60] SANADA Y,MATSUMOTO K,URAHASHI T,et al. Protocol liver biopsy is the only examination that can detect mid-term graft fibrosis after pediatric liver transplantation[J]. World J Gastroenterol,2014,20(21):6638-6650.
|
|
[61] VENTURI C,SEMPOUX C,QUINONES JA,et al. Dynamics of allograft fibrosis in pediatric liver transplantation[J]. Am J Transplant,2014,14(7):1648-1656.
|
|
[62] PONS JA,RAMIREZ P,REVILLA-NUIN B,et al. Immunosuppression withdrawal improves long-term metabolic parameters,cardiovascular risk factors and renal function in liver transplant patients[J]. Clin Transplant,2009,23(3):329-336.
|
|
[63] PERITO ER,MOHAMMAD S,ROSENTHAL P,et al. Posttransplant metabolic syndrome in the withdrawal of immunosuppression in Pediatric Liver Transplant Recipients(WISPR)pilot trial[J]. Am J Transplant,2015,15(3):779-785.
|
|
[64] ZHENG HB,WATKINS B,TKACHEV V,et al. The knife’s edge of tolerance:Inducing stable multilineage mixed chimerism but with a significant risk of CMV reactivation and disease in rhesus macaques[J]. Am J Transplant,2017,17(3):657-670.
|
|
[65] FENG S,BUCUVALAS J. Tolerance after liver transplantation:Where are we?[J]. Liver Transpl,2017,23(12):1601-1614.
|
DownLoad: